Downregulation of ATF4 was however shown to prevent cancer cells resistance to anticancer drugs [21], indicating that a minimal expression of ATF4, which is driven by P-eIF2α is nevertheless required for cancer cells survival to chemotherapeutics. The gene discussed is ATF4; the disease is cancer.